MAAT PHARMA RECEIVES NEGATIVE CHMP TREND VOTE FOR MAAT013 (XERVYTEG®) FOLLOWING RE-EXAMINATION FOR ITS CONDITIONAL MARKETING AUTHORIZATION APPLICATION IN EUROPE

Reuters · 2d ago

Please log in to view news